Somatostatin Receptor Theranostics for Refractory Meningiomas

Somatostatin receptor (SSTR)-targeted peptide receptor radionuclide therapy (PRRT) represents a promising approach for treatment-refractory meningiomas progressing after surgery and radiotherapy. The aim of this study was to provide outcomes of patients harboring refractory meningiomas treated by 17...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgues, Betty, Graillon, Thomas, Horowitz, Tatiana, Chinot, Olivier, Padovani, Laetitia, Taïeb, David, Guedj, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406720/
https://www.ncbi.nlm.nih.gov/pubmed/36005176
http://dx.doi.org/10.3390/curroncol29080438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406720/
https://www.ncbi.nlm.nih.gov/pubmed/36005176
http://dx.doi.org/10.3390/curroncol29080438

Ejemplares similares